| 英文别名 |
2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione;GKT-137831;2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6-dione;GKT137831;2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo(4,3-c)pyridine-3,6(2H,5H)-dione;AK134876;SureCN1302603;UNII-45II35329V;Setanaxib;45II35329V;GKT 137831;setanaxib (proposed INN);GTPL9932;GKT831;AOB5773;BCP14159;DA-33605;AS-74753;SB19230;EN300-20043919;CHEMBL4303187;J-690070;HY-12298;MFCD27923122;NCGC00378460-08;NCGC00378460-05;Setanaxib (GKT137831);1H-Pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione, 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-;EX-A577;CS-3290;NCGC00378460-09;GKT137831(Setanaxib)?;Q27258840;2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-6-hydroxy-5-methylpyrazolo[4,3-c]pyridin-3-one;1H-PYRAZOLO(4,3-C)PYRIDINE-3,6(2H,5H)-DIONE, 2-(2-CHLOROPHENYL)-4-(3-(DIMETHYLAMINO)PHENYL)-5-METHYL-;AC-33132;1218942-37-0;GKT-831;2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1,2-dihydro-3H-pyrazolo[4,3-c]pyridine-3,6(5H)-dione;SCHEMBL1302603;SETANAXIB [INN];CCG-268595;2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H,2H,3H,5H,6H-pyrazolo[4,3-c]pyridine-3,6-dione;DTXSID30153432;s7171;AKOS022176138;DTXCID7075923;2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo(4,3-c)pyridine-3,6-dione;2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo[4,3-c]pyridine-3,6(2h,5h)-dione;setanaxibum;GKT 831;BRD-K79710622-001-01-1;BRD-K79710622-001-02-9 |